SEC Form D · filed July 8, 2016
Oncternal Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (25)
Scott L. Glenn · San Diego, CADirectorCam L. Garner · San Diego, CADirectorDana B. Mcgowan · San Diego, CAExecDavid F. Hale · San Diego, CADirectorBrian B. Lannutti · San Diego, CAExecLauren G. Otsuki · San Diego, CAExecDavid B. Johnson · San Diego, CADirectorJames B. Breitmeyer, M.D., Ph.D · Del Mar, CAExec · DirectorJames G. Freddo · Del Mar, CAExecThomas A. Roszak · Northfield, ILExecStan Johnson · Fargo, NDDirectorGene Smestad · Valley City, NDExecMichael A. Moceri · Chicago, ILDirectorCraig Lloyd · Sioux Falls, SDDirectorBrad Fay · Bismarck, NDExecRay Braun · Valley City, NDDirectorSteven Kay · San Francisco, CAExecMark Jorgensen · San Francisco, CADirectorDenise Woodard · Jersey City, NJDirectorJames F. Corum · Waxahachie, TXExecAllen R. Page · Waxahachie, TXDirectorCalvin E. Webb, Iii · Waxahachie, TXDirectorMichael Krupka · BOSTON, MAExecJames B. Breitmeyer, M.D., Ph.D · Del Mar, CAExec · DirectorJames G. Freddo · Del Mar, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗